What a modern preventive health checkup should actually include
A truly preventive health checkup goes well beyond fasting glucose, basic lipids, and an ECG. It includes markers of insulin resistance (fasting insulin, HOMA-IR), advanced cardiovascular risk (ApoB, lipoprotein(a), hs-CRP), body composition (visceral fat, muscle mass, not just BMI), cardiovascular fitness (VO2max or equivalent), metabolic function (HbA1c, liver markers, kidney markers including urine albumin), and age-appropriate cancer screening. The purpose is to detect biology well before it becomes disease — not to confirm disease after it has already arrived.
A reasonable modern preventive panel includes:
- Glycaemic: fasting glucose, HbA1c, fasting insulin, HOMA-IR
- Lipids (advanced): full lipid profile, plus ApoB (single best lipid marker for cardiovascular risk), plus lipoprotein(a) at least once in a lifetime
- Inflammation: high-sensitivity C-reactive protein (hs-CRP)
- Liver: ALT, AST, GGT, with attention to markers suggesting fatty liver
- Kidney: serum creatinine, eGFR, urine albumin-to-creatinine ratio
- Thyroid: TSH, with reflex T3/T4 where indicated
- Nutritional status: vitamin D, vitamin B12 (particularly in vegetarians and long-term metformin users), iron studies where indicated
- Body composition: waist circumference, BMI (interpreted with ICMR thresholds), muscle mass and visceral fat where measurement is available
- Cardiovascular fitness: VO2max, resting heart rate, heart rate recovery — where feasible
- Cancer screening: age- and risk-appropriate, discussed and arranged based on personal and family history
What is hs-CRP and why should it be in every preventive panel?
High-sensitivity C-reactive protein (hs-CRP) is a blood marker of low-grade systemic inflammation. Elevated hs-CRP is independently associated with increased risk of cardiovascular events, diabetes, and overall mortality — even in people whose cholesterol and glucose look fine. It is inexpensive, widely available, and profoundly underused in Indian preventive checkups. An hs-CRP below 1.0 mg/L suggests low cardiovascular risk; 1.0–3.0 mg/L is intermediate; above 3.0 mg/L is elevated and warrants clinical attention.
Why it matters:
- Chronic low-grade inflammation is a quiet driver of atherosclerosis, diabetes progression, and long-term metabolic disease — often present long before conventional markers change
- Elevated hs-CRP in an otherwise ‘normal’ panel identifies risk that LDL cholesterol and fasting glucose miss
- hs-CRP is modifiable — body composition improvement, metabolic health, sleep, and specific anti-inflammatory interventions move the number in the right direction
- A single elevated hs-CRP should be repeated before drawing conclusions — acute illness and recent infection transiently raise it. The pattern matters more than one reading.
Fasting insulin and HOMA-IR — the tests most checkups skip
Fasting insulin measures the level of circulating insulin after an overnight fast; HOMA-IR is a calculated index combining fasting insulin and fasting glucose to estimate insulin resistance. Together, they detect insulin resistance years before fasting glucose or HbA1c rise into diabetic ranges — the window where intervention is most effective. These tests are inexpensive, widely available, and genuinely underused in Indian preventive checkups that focus on glucose alone.
The clinical picture that emerges from running fasting insulin in a preventive panel:
- Normal fasting insulin is typically <10 µU/mL; ideally 2–6 µU/mL in metabolically healthy adults. Many Indian patients with ‘normal’ glucose have fasting insulin 2–3 times this upper limit — significant insulin resistance that standard screening misses entirely.
- HOMA-IR below 1.0 suggests good insulin sensitivity; 1.0–2.0 is reasonable; above 2.5 suggests meaningful insulin resistance warranting intervention.
- Rising fasting insulin precedes rising HbA1c by years — sometimes a decade. Early detection reshapes the preventive trajectory.
- Insulin resistance reversibility is best in the pre-diabetic window — which is precisely the window these tests identify.
ApoB — the single best lipid marker for cardiovascular risk
Apolipoprotein B (ApoB) measures the total number of atherogenic particles in the blood — LDL, VLDL, IDL, and lipoprotein(a) combined. Modern cardiovascular risk assessment increasingly recognises ApoB as a more accurate predictor of atherosclerotic disease than LDL cholesterol alone, particularly in patients with metabolic syndrome, diabetes, or mixed dyslipidaemia. It captures risk that LDL-C can miss.
Why ApoB deserves to be in modern preventive panels:
- LDL cholesterol measures the mass of cholesterol inside LDL particles; ApoB counts the particles themselves. When particle number and cholesterol content don’t match (common in insulin resistance, diabetes, metabolic syndrome), LDL-C understates risk.
- Treatment decisions increasingly use ApoB as a target — many guidelines now recommend ApoB goals for higher-risk patients
- ApoB is not routinely run in standard Indian checkups despite being inexpensive and widely available
- Lipoprotein(a) — genetically determined, unmodifiable through lifestyle — should also be measured at least once in a lifetime; combined with ApoB, it gives a comprehensive lipid risk picture
Body composition and fitness — the measurements that outperform BMI
BMI is a crude population-level metric that routinely misclassifies individual risk — particularly in South Asian patients whose visceral fat concentration at lower BMIs produces early metabolic disease. Body composition (muscle mass, visceral fat, waist circumference) and cardiovascular fitness (VO2max or equivalent) predict long-term health outcomes substantially better than BMI alone. A preventive assessment that ignores body composition and fitness is missing some of the most important signals available.
What body composition reveals
Two adults at the same weight can have very different metabolic pictures. Waist circumference (≥90 cm for Indian men, ≥80 cm for Indian women indicates elevated risk), visceral fat percentage, and muscle mass relative to fat mass all contribute to long-term risk in ways that BMI alone does not capture. Low muscle mass — particularly in adults over 50 — is an underappreciated risk factor for frailty, insulin resistance, and reduced lifespan.
What cardiovascular fitness reveals
VO2max — maximum oxygen uptake capacity — is one of the strongest predictors of all-cause mortality available in clinical medicine. A person with low VO2max has substantially higher long-term risk than a person with high VO2max, independent of weight, smoking, or traditional risk factors. Improving fitness is one of the highest-leverage modifications available. Even rough fitness assessment (heart rate recovery, functional capacity testing) tells you something the standard checkup ignores entirely.
Biological age — useful concept, overhyped marketing
Biological age refers to an estimate of how old your body is physiologically, based on biomarkers, rather than how old the calendar says you are. Several biological age calculators and DNA methylation tests exist, with varying levels of scientific validation. The concept is useful as a framing for preventive care; the specific commercial ‘biological age’ tests vary widely in quality and clinical utility. We take the concept seriously without over-paying for fashionable tests that don’t change management decisions.
Our honest position:
- The idea that biomarkers can estimate physiological age is valid and increasingly supported by research
- Practical biological age — insulin sensitivity, body composition, cardiovascular fitness, inflammation, metabolic health — is strongly predicted by a careful preventive panel, whether or not a commercial ‘biological age’ calculator is involved
- Some commercial biological-age tests (epigenetic clocks, telomere length assays) are interesting but expensive, and many don’t change management decisions in ways that justify the cost
- We discuss biological age testing honestly with interested patients — what’s useful, what’s hype — and include it where it adds real value, not because it’s trending
The nutrition gap most Indian adults don't know they have
The biggest nutritional threat to healthy aging in India is not overeating — it is protein undernutrition. Most Indian adults over 45 eat a diet adequate in calories but severely inadequate in protein. A standard dal-roti lunch gives 12–15 grams of protein. The same meal needs 25–30 grams to preserve muscle and satisfy hunger properly. This gap, repeated across three meals every day for decades, is a primary driver of sarcopenia — the gradual loss of muscle mass and strength — and the metabolic fragility that follows.
Sarcopenia is not inevitable, but it is normal when protein is consistently insufficient. Its consequences extend well beyond feeling physically weaker: muscle tissue is metabolically active, and losing it accelerates insulin resistance, cognitive slowing, and bone density loss. After the age of 50, the body becomes progressively less efficient at using dietary protein for muscle synthesis — which means protein needs actually increase with age, not decrease. A 60-year-old needs more protein per kilogram of body weight than a 30-year-old to achieve the same muscle-building response.
The practical translation: dal is a side dish. Eggs, paneer, curd, fish, and chicken are the proteins that fill the gap — all familiar, all affordable, all available in a Delhi kitchen. We plan for a real protein source at every meal, specifically, rather than assuming the background diet covers it.
Anti-inflammatory eating is the second lever for healthy aging. Chronic low-grade inflammation — measured by markers like hs-CRP — accelerates nearly every age-related disease process. The anti-inflammatory kitchen is not complicated: ghee rather than refined seed oils, turmeric generously in daily cooking, fatty fish regularly, abundant vegetables especially the green leafy ones, and minimising ultra-processed food and packaged snacks.
Gut health matters increasingly as we age. Stomach acid reduces, gut motility slows, and the microbiome changes in ways that affect digestion, immunity, and even mood. Curd daily, fermented foods where they suit the patient, and adequate fibre from dal and vegetables are the practical tools. The Indian kitchen already has these. The question is whether they are being used consistently.
Vitamin D is near-universally deficient in Delhi patients, regardless of how much time they spend outdoors — melanin, indoor lifestyle, and air pollution together make sun-based vitamin D synthesis unreliable in this population. Testing and correcting this is one of the first things we do. Low vitamin D worsens insulin resistance, muscle strength, bone density, and immune function — it is not a minor nutritional detail.
Who this program is for — and who it is not for
This program is designed for
- Adults 30+ who want a proper, structured picture of their long-term health risk — and a real plan to act on it
- People with strong family history of diabetes, cardiovascular disease, or metabolic conditions
- People who have been doing 'yearly checkups' for years and want something genuinely more useful
- People currently healthy on standard tests but intuitively aware that something may be brewing — weight creep, declining fitness, family-history worry
- People who want specific modern biomarkers (hs-CRP, ApoB, fasting insulin, HOMA-IR, Lp(a)) in their assessment — and a clinician who knows what to do with the results
- Adults serious about staying metabolically and cardiovascularly healthy into later life, not just 'catching things early'
This program is not designed for
- One-off checkup packages where the patient wants a printed report and no ongoing conversation
- People seeking advanced genetic testing, epigenetic clocks, or expensive fashionable biomarkers that don't change management
- People looking for supplement recommendations as their primary health strategy
- People with acute medical problems — those belong in specialist or emergency care first
How the program works
The program runs in three phases. First, a comprehensive baseline assessment that includes the full modern preventive panel, body composition, fitness evaluation, and detailed history-taking. Second, an individualised plan addressing whatever the assessment reveals — emerging insulin resistance, early inflammation, body composition, fitness gaps, nutrition, sleep, stress. Third, structured follow-up — typically 6–12 month review cycles with retests of relevant markers and plan adjustments.
Phase 1: Comprehensive baseline
Full modern preventive panel (glycaemic, lipid including ApoB and Lp(a), inflammation including hs-CRP, liver, kidney, thyroid, nutritional), body composition, waist circumference, fitness assessment where feasible, and a detailed conversation about personal and family history, lifestyle, sleep, stress, diet, and current medications or supplements.
Phase 2: Individualised plan
Based on your biomarker results, we identify the specific levers most worth pulling for your biology: protein adequacy at every meal to prevent muscle loss, cooking fat and inflammation corrections, movement priorities, sleep and stress interventions, targeted supplements where evidence supports them, and specialist referrals where warranted. Calibrated to your actual life, not a generic template.
Phase 3: Structured follow-up
Preventive health is not a one-off service. Typical follow-up runs at 6 or 12 month intervals depending on what the baseline showed, with retests of the markers most relevant to your picture and plan adjustments based on what changed. Major life transitions — job change, pregnancy, new medication, significant weight change — often warrant earlier review.
Why this differs from standard hospital checkup packages
Hospital checkup packages are optimised for volume, consistency, and throughput — the same panel is run for most patients, with results reviewed in a short standardised consultation. Our preventive program is built for depth, interpretation, and individualisation — a longer assessment, modern biomarkers most packages skip, and a working relationship with a clinician who will be looking at the data with you over time. Both have a role. The differences matter more than marketing language implies.
Scope: we run the markers that actually predict risk (hs-CRP, ApoB, fasting insulin, HOMA-IR, Lp(a), body composition) — standard packages usually don’t
Interpretation: results are reviewed in a proper clinical conversation, not handed over with highlighted abnormalities
Continuity: the same clinician follows your trajectory over years, not rotating through a hospital department
Action orientation: the assessment produces a plan you can actually act on, not a report to file in a drawer
Honest scope: we are not a substitute for cardiology, oncology, or specialist care where indicated — we coordinate referrals where they are needed
